Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Original Research
Measuring the Value of Treatment to Patients: Patient-Reported Outcomes in Drug Development
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
FDA Approvals
Approvable Letters in 2007 and the Outlook for 2008
Read More
Practice Management
The 2007 Pharmaceutical and Biotech Pipeline Year-End Summary: What it Says About the State of the Art of Discovery & Development
Read More
Perspectives
Contracting for Compliance: Using Adherence as a Patient-Centered Measure of Performance
Read More
Practice Management
Wayward Prescriptions: Costs of Fraud in Payor Plans
Stakeholder Perspective
Procedures Needed to Prevent Prescription Fraud
Read More
Bustling Pipeline for Diabetes and Its Metabolic Consequences
Read More
Practice Management
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Read More
FDA Approvals
Heparin at the Center of the Storm
Read More
Original Research
Prescribing Warfarin Appropriately to Meet Patient Safety Goals
Stakeholder Perspective
Benefits of Genetic Testing in Warfarin Therapy
Read More
Practice Management
Treading Water: The No-Growth Investment in Health Services Research
Stakeholder Perspective
The Golden Age of Health Services Research
Read More
230
231
232
233
234
235
236
Page 233 of 244
Results 2321 - 2330 of 2434